601 Sequencing immunotherapy before lymphatic ablation unleashes cDC1-dependent antitumor immunity in HNSCC

• Bernard Fox,
• Ezra Cohen,
• Shawn Jensen,
• Zhiyong Wang,
• Aaron Simon,
• Robert Saddawi-Konefka,
• Aoife O’Farrell,
• Andrew Sharabi,
• Joseph Califano,
• J Silvio Gutkind,
• Farhoud Faraji,
• Michael Allevato,
• Victoria Wu,
• Bryan Yung,
• Nana-Ama Anang,
• Ida Franiak-Pietryga

Affiliations

Bernard Fox

Aff3 grid.415337.7Earle A. Chiles Research InstituteProvidence Cancer Center Portland USA

Ezra Cohen

Department of Pediatrics, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA

Shawn Jensen

Aff90 grid.415337.7Providence Cancer Center Portland OR USA

Zhiyong Wang

1 Department of Non-communicable Disease Prevention, Nanjing Municipal Center for Disease Control and Prevention, Nanjing, China

Aaron Simon

1 School of Population Health, The University of New South Wales, Sydney, New South Wales, Australia

Robert Saddawi-Konefka

UC San Diego School of Medicine, San Diego, CA, USA

Aoife O’Farrell

UC San Diego School of Medicine, San Diego, CA, USA

Andrew Sharabi

UC San Diego School of Medicine, San Diego, CA, USA

Joseph Califano

UC San Diego School of Medicine, San Diego, CA, USA

J Silvio Gutkind

UC San Diego School of Medicine, San Diego, CA, USA

Farhoud Faraji

1UC San Diego School of Medicine, La Jolla, CA, USA

Michael Allevato

1UC San Diego School of Medicine, La Jolla, CA, USA

Victoria Wu

1UC San Diego School of Medicine, La Jolla, CA, USA

Bryan Yung

1UC San Diego School of Medicine, La Jolla, CA, USA

Nana-Ama Anang

1UC San Diego School of Medicine, La Jolla, CA, USA

Ida Franiak-Pietryga

1UC San Diego School of Medicine, La Jolla, CA, USA